Keywords: speedel, board, backs, novartis, offer, basel, switzerland-based
Speedel board backs Novartis offer
Article | 11 August 2008
Basel, Switzerland-based Speedel Holding says that its board of directors has recommended the public tender offer previously-announced by Novartis on ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Is failure to adopt business process management putting the pharma industry at risk?
- New Zealand declines Alexion's funding application for Solaris
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- Elan makes "transformational" acquisitions and a divestment
